David Berd
Impact in
- Microbiology top 0.5%
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
- Immunology 72
- Immunotherapy and Immune Responses 62
- Immune Cell Function and Interaction 13
- Oncology 55
- Cancer Immunotherapy and Biomarkers 24
- CAR-T cell therapy research 20
- Cutaneous Melanoma Detection and Management 14
- Co-authors
- Michael J. Mastrangelo (65 shared papers)Henry C. Maguire Jr. (19 shared papers)Takami Sato (23 shared papers)Robert E. Bellet (10 shared papers)Peter A. McCue (6 shared papers)Carol L. Shields (8 shared papers)Jerry A. Shields (7 shared papers)Gëorge F. Murphy (6 shared papers)
- Journals
- Cancer Immunology Immunotherapy (12 papers)Journal of Clinical Oncology (7 papers)Melanoma Research (4 papers)International Journal of Cancer (4 papers)Cancer (4 papers)
- Partner nations
- United StatesJapanItaly
In The Last Decade
David Berd
117 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 128
- Microbiology 159
- Immunology 2.2k
- Oncology 2.1k
- Ophthalmology 518
- Cancer Research 359
Countries citing papers authored by David Berd
This map shows the geographic impact of David Berd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Berd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Berd more than expected).
Fields of papers citing papers by David Berd
This network shows the impact of papers produced by David Berd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Berd. The network helps show where David Berd may publish in the future.
Co-authors
The 25 scholars most cited alongside David Berd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1990 | 263 | |
| 2 | Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide. | 1986 | 215 |
| 3 | Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma. | 1994 | 153 |
| 4 | 1973 | 145 | |
| 5 | Effect of low dose cyclophosphamide on the immune system of cancer patients: depletion of CD4+, 2H4+ suppressor-inducer T-cells. | 1988 | 143 |
| 6 | Regulation of intracellular pH in human melanoma: potential therapeutic implications. | 2002 | 131 |
| 7 | 1992 | 120 | |
| 8 | Augmentation of the human immune response by cyclophosphamide. | 1982 | 120 |
| 9 | 2003 | 118 | |
| 10 | 2000 | 116 | |
| 11 | Potentiation of human cell-mediated and humoral immunity by low-dose cyclophosphamide. | 1984 | 109 |
| 12 | Abnormal expression of perlecan proteoglycan in metastatic melanomas. | 1994 | 109 |
| 13 | 1997 | 108 | |
| 14 | 2005 | 104 | |
| 15 | Interleukin 10 production by human melanoma. | 1996 | 102 |
| 16 | 1989 | 100 | |
| 17 | 1975 | 88 | |
| 18 | Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma. | 1987 | 88 |
| 19 | 1996 | 82 | |
| 20 | Effect of low dose cyclophosphamide on the immune system of cancer patients: reduction of T-suppressor function without depletion of the CD8+ subset. | 1987 | 81 |
About David Berd
David Berd is a scholar working on Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Ophthalmology, having authored 119 papers that have together received 4.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (62 papers), Cancer Immunotherapy and Biomarkers (24 papers), CAR-T cell therapy research (20 papers), Monoclonal and Polyclonal Antibodies Research (17 papers), Cutaneous Melanoma Detection and Management (14 papers), Immune Cell Function and Interaction (13 papers), Melanoma and MAPK Pathways (9 papers) and Cancer Research and Treatments (8 papers). The work is most often cited by research in Microbiology (159 citations), Immunology (2.2k citations), Oncology (2.1k citations), Ophthalmology (518 citations) and Cancer Research (359 citations). David Berd has collaborated with scholars based in United States, Japan and Italy. Frequent co-authors include Michael J. Mastrangelo, Henry C. Maguire Jr., Takami Sato, Robert E. Bellet, Peter A. McCue, Carol L. Shields, Jerry A. Shields, Gëorge F. Murphy, Edmund C. Lattime and Mastrangelo Mj. Their work appears in journals such as Cancer Immunology Immunotherapy, Journal of Clinical Oncology, Melanoma Research, International Journal of Cancer and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.